TreeWAS – Variant ID: rs1108252

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
G57.6 Lesion of plantar nerve	0.021	0.979	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.021	0.979	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.021	0.979	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.020	0.980	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.020	0.980	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.019	0.980	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.018	0.982	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.018	0.982	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.018	0.982	0.000
T42.0 Hydantoin derivatives	0.018	0.982	0.000
T45.5 Anticoagulants	0.017	0.983	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.017	0.983	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.017	0.983	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.017	0.983	0.000
T45.0 Antiallergic and antiemetic drugs	0.017	0.983	0.000
T42.1 Iminostilbenes	0.017	0.983	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.016	0.983	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.016	0.984	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.016	0.984	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.016	0.984	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.016	0.984	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.016	0.984	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.015	0.984	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.015	0.984	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.015	0.984	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.015	0.984	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.015	0.984	0.000
T46.7 Peripheral vasodilators	0.015	0.984	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.015	0.984	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.015	0.984	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.015	0.984	0.000
T46.1 Calcium-channel blockers	0.015	0.984	0.000
T36 Poisoning by systemic antibiotics	0.015	0.985	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.015	0.985	0.000
Q61.3 Polycystic kidney, unspecified	0.000	0.985	0.015
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.014	0.985	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.014	0.985	0.000
T42.3 Barbiturates	0.014	0.985	0.000
T42.2 Succinimides and oxazolidinediones	0.014	0.985	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.015	0.985	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.014	0.986	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.014	0.986	0.000
T45.8 Other primarily systemic and haematological agents	0.014	0.986	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.014	0.986	0.000
T45.6 Fibrinolysis-affecting drugs	0.014	0.986	0.000
T45.4 Iron and its compounds	0.014	0.986	0.000
T45.3 Enzymes, not elsewhere classified	0.014	0.986	0.000
T45.2 Vitamins, not elsewhere classified	0.014	0.986	0.000
T38.1 Thyroid hormones and substitutes	0.014	0.986	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.014	0.986	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.014	0.986	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.014	0.986	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.014	0.986	0.000
T40.5 Cocaine	0.013	0.986	0.000
T50.4 Drugs affecting uric acid metabolism	0.013	0.987	0.000
T40.4 Other synthetic narcotics	0.013	0.987	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.013	0.987	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.013	0.987	0.000
T47.7 Emetics	0.013	0.987	0.000
T47.6 Antidiarrhoeal drugs	0.013	0.987	0.000
T47.5 Digestants	0.013	0.987	0.000
T47.4 Other laxatives	0.013	0.987	0.000
T47.3 Saline and osmotic laxatives	0.013	0.987	0.000
T47.2 Stimulant laxatives	0.013	0.987	0.000
T47.0 Histamine H(2)-receptor antagonists	0.013	0.987	0.000
T38.9 Other and unspecified hormone antagonists	0.013	0.987	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.013	0.987	0.000
T38.7 Androgens and anabolic congeners	0.013	0.987	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.013	0.987	0.000
T38.5 Other oestrogens and progestogens	0.013	0.987	0.000
T38.4 Oral contraceptives	0.013	0.987	0.000
T38.2 Antithyroid drugs	0.013	0.987	0.000
T38.0 Glucocorticoids and synthetic analogues	0.013	0.987	0.000
T50.8 Diagnostic agents	0.013	0.987	0.000
T50.7 Analeptics and opioid receptor antagonists	0.013	0.987	0.000
T50.5 Appetite depressants	0.013	0.987	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.013	0.987	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.013	0.987	0.000
T50.1 Loop [high-ceiling] diuretics	0.013	0.987	0.000
T50.0 Mineralocorticoids and their antagonists	0.013	0.987	0.000
T42.4 Benzodiazepines	0.013	0.987	0.000
T49.9 Topical agent, unspecified	0.012	0.987	0.000
T49.8 Other topical agents	0.012	0.987	0.000
T49.7 Dental drugs, topically applied	0.012	0.987	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.012	0.987	0.000
T49.5 Ophthalmological drugs and preparations	0.012	0.987	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.012	0.987	0.000
T49.3 Emollients, demulcents and protectants	0.012	0.987	0.000
T49.2 Local astringents and local detergents	0.012	0.987	0.000
T49.1 Antipruritics	0.012	0.987	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.012	0.987	0.000
Q61 Cystic kidney disease	0.000	0.988	0.012
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.012	0.988	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.012	0.988	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.012	0.988	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.012	0.988	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.012	0.988	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.012	0.988	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.012	0.988	0.000
T44.0 Anticholinesterase agents	0.012	0.988	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.012	0.988	0.000
T40.8 Lysergide [LSD]	0.012	0.988	0.000
T40.7 Cannabis (derivatives)	0.012	0.988	0.000
T40.3 Methadone	0.012	0.988	0.000
T40.1 Heroin	0.012	0.988	0.000
T40.0 Opium	0.012	0.988	0.000
T43.9 Psychotropic drug, unspecified	0.012	0.988	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.012	0.988	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.012	0.988	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.011	0.989	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.011	0.989	0.000
T37.5 Antiviral drugs	0.011	0.989	0.000
T37.4 Anthelminthics	0.011	0.989	0.000
T37.3 Other antiprotozoal drugs	0.011	0.989	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.011	0.989	0.000
T37.1 Antimycobacterial drugs	0.011	0.989	0.000
T37.0 Sulphonamides	0.011	0.989	0.000
T41.5 Therapeutic gases	0.011	0.989	0.000
T41.4 Anaesthetic, unspecified	0.011	0.989	0.000
T41.3 Local anaesthetics	0.011	0.989	0.000
T41.2 Other and unspecified general anaesthetics	0.011	0.989	0.000
T41.1 Intravenous anaesthetics	0.011	0.989	0.000
T41.0 Inhaled anaesthetics	0.011	0.989	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.011	0.989	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.011	0.989	0.000
T48.5 Anti-common-cold drugs	0.011	0.989	0.000
T48.4 Expectorants	0.011	0.989	0.000
T48.3 Antitussives	0.011	0.989	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.011	0.989	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.011	0.989	0.000
T48.0 Oxytocic drugs	0.011	0.989	0.000
T36.9 Systemic antibiotic, unspecified	0.011	0.989	0.000
T36.8 Other systemic antibiotics	0.011	0.989	0.000
T36.7 Antifungal antibiotics, systemically used	0.011	0.989	0.000
T36.6 Rifamycins	0.011	0.989	0.000
T36.5 Aminoglycosides	0.011	0.989	0.000
T36.4 Tetracyclines	0.011	0.989	0.000
T36.3 Macrolides	0.011	0.989	0.000
T36.2 Chloramphenicol group	0.011	0.989	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.011	0.989	0.000
T43.6 Psychostimulants with abuse potential	0.011	0.989	0.000
Q61.2 Polycystic kidney, adult type	0.000	0.989	0.011
Q61.5 Medullary cystic kidney	0.000	0.989	0.011
T40.6 Other and unspecified narcotics	0.011	0.989	0.000
T36.0 Penicillins	0.011	0.989	0.000
T43.2 Other and unspecified antidepressants	0.011	0.989	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.011	0.989	0.000
Q61.9 Cystic kidney disease, unspecified	0.000	0.990	0.010
I46.9 Cardiac arrest, unspecified	0.000	0.990	0.010
T43.3 Phenothiazine antipsychotics and neuroleptics	0.009	0.990	0.000
T40.2 Other opioids	0.009	0.991	0.000
Q61.8 Other cystic kidney diseases	0.000	0.991	0.009
Q61.4 Renal dysplasia	0.000	0.991	0.009
Q61.1 Polycystic kidney, infantile type	0.000	0.991	0.009
Q61.0 Congenital single renal cyst	0.000	0.992	0.008
I46.0 Cardiac arrest with successful resuscitation	0.000	0.992	0.008
G57 Mononeuropathies of lower limb	0.008	0.992	0.000
I46 Cardiac arrest	0.000	0.992	0.008
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.007	0.993	0.000
G57.3 Lesion of lateral popliteal nerve	0.007	0.993	0.000
M50.2 Other cervical disk displacement	0.000	0.994	0.006
T43.0 Tricyclic and tetracyclic antidepressants	0.006	0.994	0.000
Q60-Q64 Congenital malformations of the urinary system	0.000	0.994	0.006
G57.1 Meralgia paraesthetica	0.006	0.994	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.006	0.994	0.000
K82.4 Cholesterolosis of gallbladder	0.006	0.994	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.006	0.994	0.000
G57.4 Lesion of medial popliteal nerve	0.006	0.994	0.000
G57.2 Lesion of femoral nerve	0.006	0.994	0.000
I46.1 Sudden cardiac death, so described	0.000	0.994	0.006
G57.0 Lesion of sciatic nerve	0.006	0.994	0.000
G57.9 Mononeuropathy of lower limb, unspecified	0.006	0.994	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.006	0.994	0.000
T39.4 Antirheumatics, not elsewhere classified	0.005	0.995	0.000
T39.2 Pyrazolone derivatives	0.005	0.995	0.000
Q63 Other congenital malformations of kidney	0.000	0.995	0.005
T51.0 Ethanol	0.005	0.995	0.000
Q63.0 Accessory kidney	0.000	0.995	0.005
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.005	0.995	0.000
G57.5 Tarsal tunnel syndrome	0.005	0.995	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.005	0.995	0.000
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.005	0.995	0.000
T39.0 Salicylates	0.005	0.995	0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.000	0.995	0.004
D68.9 Coagulation defect, unspecified	0.005	0.995	0.000
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.004	0.995	0.000
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.004	0.996	0.000
Q64 Other congenital malformations of urinary system	0.000	0.996	0.004
L05.9 Pilonidal cyst without abscess	0.000	0.996	0.004
O24.4 Diabetes mellitus arising in pregnancy	0.000	0.996	0.004
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.004	0.996	0.000
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.004	0.996	0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.004	0.996	0.000
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.004	0.996	0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.004	0.996	0.000
G57.8 Other mononeuropathies of lower limb	0.004	0.996	0.000
Q63.9 Congenital malformation of kidney, unspecified	0.000	0.996	0.004
Q63.8 Other specified congenital malformations of kidney	0.000	0.996	0.004
Q63.3 Hyperplastic and giant kidney	0.000	0.996	0.004
Q63.1 Lobulated, fused and horseshoe kidney	0.000	0.996	0.004
T39.1 4-Aminophenol derivatives	0.004	0.996	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.004	0.996	0.000
Q63.2 Ectopic kidney	0.000	0.996	0.004
Q60 Renal agenesis and other reduction defects of kidney	0.000	0.996	0.004
M23.39 Other meniscus derangements (Unspecified ligament or Unspecified meniscus)	0.004	0.996	0.000
G83.4 Cauda equina syndrome	0.000	0.996	0.004
Q62.8 Other congenital malformations of ureter	0.000	0.996	0.003
Q62.7 Congenital vesico-uretero-renal reflux	0.000	0.996	0.003
Q62.6 Malposition of ureter	0.000	0.996	0.003
Q62.5 Duplication of ureter	0.000	0.996	0.003
Q62.4 Agenesis of ureter	0.000	0.996	0.003
Q62.3 Other obstructive defects of renal pelvis and ureter	0.000	0.996	0.003
Q62.2 Congenital megaloureter	0.000	0.996	0.003
Q62.1 Atresia and stenosis of ureter	0.000	0.996	0.003
Q62.0 Congenital hydronephrosis	0.000	0.996	0.003
C18.2 Ascending colon	0.000	0.997	0.003
Q64.9 Congenital malformation of urinary system, unspecified	0.000	0.997	0.003
Q64.8 Other specified congenital malformations of urinary system	0.000	0.997	0.003
Q64.7 Other congenital malformations of bladder and urethra	0.000	0.997	0.003
Q64.6 Congenital diverticulum of bladder	0.000	0.997	0.003
Q64.5 Congenital absence of bladder and urethra	0.000	0.997	0.003
Q64.4 Malformation of urachus	0.000	0.997	0.003
Q64.2 Congenital posterior urethral valves	0.000	0.997	0.003
Q64.1 Exstrophy of urinary bladder	0.000	0.997	0.003
Q64.0 Epispadias	0.000	0.997	0.003
C77.8 Lymph nodes of multiple regions	0.003	0.997	0.000
Z86.5 Personal history of other mental and behavioural disorders	0.000	0.997	0.003
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.000	0.997	0.003
O23.4 Unspecified infection of urinary tract in pregnancy	0.000	0.997	0.003
R07.0 Pain in throat	0.000	0.997	0.003
L28.0 Lichen simplex chronicus	0.003	0.997	0.000
S42.30 Fracture of shaft of humerus (closed)	0.000	0.997	0.003
D41.4 Bladder	0.000	0.997	0.003
Q60.6 Potter's syndrome	0.000	0.997	0.003
Q60.5 Renal hypoplasia, unspecified	0.000	0.997	0.003
Q60.4 Renal hypoplasia, bilateral	0.000	0.997	0.003
Q60.3 Renal hypoplasia, unilateral	0.000	0.997	0.003
Q60.1 Renal agenesis, bilateral	0.000	0.997	0.003
J39.2 Other diseases of pharynx	0.000	0.997	0.003
T51 Toxic effect of alcohol	0.003	0.997	0.000
M05 Seropositive rheumatoid arthritis	0.003	0.997	0.000
O24 Diabetes mellitus in pregnancy	0.000	0.997	0.003
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.000	0.997	0.003
N70.1 Chronic salpingitis and oophoritis	0.000	0.997	0.003
Z74.1 Need for assistance with personal care	0.003	0.997	0.000
I34.1 Mitral (valve) prolapse	0.003	0.997	0.000
Q60.2 Renal agenesis, unspecified	0.000	0.997	0.003
T83.4 Mechanical complication of other prosthetic devices, implants and grafts in genital tract	0.003	0.997	0.000
D68.5 Primary Thrombophilia	0.003	0.997	0.000
H11.3 Conjunctival haemorrhage	0.000	0.997	0.003
R03.0 Elevated blood-pressure reading, without diagnosis of hypertension	0.003	0.997	0.000
T83.3 Mechanical complication of intra-uterine contraceptive device	0.003	0.997	0.000
M06.9 Rheumatoid arthritis, unspecified	0.000	0.997	0.003
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.000	0.997	0.003
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.997	0.003
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.997	0.003
H11.4 Other conjunctival vascular disorders and cysts	0.000	0.997	0.003
M05.1 Rheumatoid lung disease	0.002	0.997	0.000
Q60.0 Renal agenesis, unilateral	0.000	0.997	0.002
T79.7 Traumatic subcutaneous emphysema	0.000	0.998	0.002
T51.8 Other alcohols	0.002	0.998	0.000
T51.3 Fusel oil	0.002	0.998	0.000
T51.2 2-Propanol	0.002	0.998	0.000
T51.1 Methanol	0.002	0.998	0.000
O23 Infections of genito-urinary tract in pregnancy	0.000	0.998	0.002
D68 Other coagulation defects	0.002	0.998	0.000
O24.9 Diabetes mellitus in pregnancy, unspecified	0.000	0.998	0.002
T83 Complications of genito-urinary prosthetic devices, implants and grafts	0.002	0.998	0.000
C77.5 Intrapelvic lymph nodes	0.002	0.998	0.000
T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system	0.002	0.998	0.000
Z45.8 Adjustment and management of other implanted devices	0.002	0.998	0.000
M05.3 Rheumatoid arthritis with involvement of other organs and systems	0.002	0.998	0.000
M05.2 Rheumatoid vasculitis	0.002	0.998	0.000
M05.0 Felty's syndrome	0.002	0.998	0.000
O24.3 Pre-existing diabetes mellitus, unspecified	0.000	0.998	0.002
O24.2 Pre-existing malnutrition-related diabetes mellitus	0.000	0.998	0.002
O24.1 Pre-existing diabetes mellitus, noninsulin-dependent	0.000	0.998	0.002
S42.3 Fracture of shaft of humerus	0.000	0.998	0.002
Z35.8 Supervision of other high-risk pregnancies	0.000	0.998	0.002
M05.8 Other seropositive rheumatoid arthritis	0.002	0.998	0.000
M05.19 Rheumatoid lung disease (Site unspecified)	0.002	0.998	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
Z74.9 Problem related to care-provider dependency, unspecified	0.002	0.998	0.000
H53.8 Other visual disturbances	0.000	0.998	0.002
S42.40 Fracture of lower end of humerus (closed)	0.000	0.998	0.002
H11.8 Other specified disorders of conjunctiva	0.000	0.998	0.002
Z74 Problems related to care-provider dependency	0.002	0.998	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.998	0.002
T83.1 Mechanical complication of other urinary devices and implants	0.002	0.998	0.000
O24.0 Pre-existing diabetes mellitus, insulin-dependent	0.000	0.998	0.002
Z74.2 Need for assistance at home and no other household member able to render care	0.002	0.998	0.000
T83.6 Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract	0.002	0.998	0.000
T83.0 Mechanical complication of urinary (indwelling) catheter	0.002	0.998	0.000
H11 Other disorders of conjunctiva	0.000	0.998	0.002
C79.7 Secondary malignant neoplasm of adrenal gland	0.000	0.998	0.002
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.002	0.998	0.000
M05.18 Rheumatoid lung disease (Other)	0.002	0.998	0.000
M05.17 Rheumatoid lung disease (Ankle and foot)	0.002	0.998	0.000
M05.16 Rheumatoid lung disease (Lower leg)	0.002	0.998	0.000
M05.15 Rheumatoid lung disease (Pelvic region and thigh)	0.002	0.998	0.000
M05.14 Rheumatoid lung disease (Hand)	0.002	0.998	0.000
M05.13 Rheumatoid lung disease (Forearm)	0.002	0.998	0.000
M05.12 Rheumatoid lung disease (Upper arm)	0.002	0.998	0.000
M05.11 Rheumatoid lung disease (Shoulder region)	0.002	0.998	0.000
M05.10 Rheumatoid lung disease (Multiple sites)	0.002	0.998	0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.000	0.998	0.002
M79.70 Fibromyalgia (Multiple sites)	0.002	0.998	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.000	0.998	0.002
O23.9 Other and unspecified genito-urinary tract infection in pregnancy	0.000	0.998	0.002
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
S42.4 Fracture of lower end of humerus	0.000	0.998	0.002
T83.9 Unspecified complication of genito-urinary prosthetic device, implant and graft	0.002	0.998	0.000
Z35.0 Supervision of pregnancy with history of infertility	0.000	0.998	0.002
O20.9 Haemorrhage in early pregnancy, unspecified	0.000	0.998	0.002
O23.3 Infections of other parts of urinary tract in pregnancy	0.000	0.998	0.002
O23.2 Infections of urethra in pregnancy	0.000	0.998	0.002
O23.1 Infections of bladder in pregnancy	0.000	0.998	0.002
O23.0 Infections of kidney in pregnancy	0.000	0.998	0.002
D68.8 Other specified coagulation defects	0.002	0.998	0.000
D68.4 Acquired coagulation factor deficiency	0.002	0.998	0.000
G83.1 Monoplegia of lower limb	0.000	0.998	0.002
G83 Other paralytic syndromes	0.000	0.998	0.002
O23.5 Infections of the genital tract in pregnancy	0.000	0.998	0.002
S43.0 Dislocation of shoulder joint	0.000	0.998	0.002
Z35.4 Supervision of pregnancy with grand multiparity	0.000	0.998	0.002
Z74.8 Other problems related to care-provider dependency	0.002	0.998	0.000
T56 Toxic effect of metals	0.002	0.998	0.000
Z35 Supervision of high-risk pregnancy	0.000	0.998	0.002
M05.09 Felty's syndrome (Site unspecified)	0.002	0.998	0.000
M05.08 Felty's syndrome (Other)	0.002	0.998	0.000
M05.07 Felty's syndrome (Ankle and foot)	0.002	0.998	0.000
M05.06 Felty's syndrome (Lower leg)	0.002	0.998	0.000
M05.05 Felty's syndrome (Pelvic region and thigh)	0.002	0.998	0.000
M05.04 Felty's syndrome (Hand)	0.002	0.998	0.000
M05.03 Felty's syndrome (Forearm)	0.002	0.998	0.000
M05.02 Felty's syndrome (Upper arm)	0.002	0.998	0.000
M05.01 Felty's syndrome (Shoulder region)	0.002	0.998	0.000
M05.00 Felty's syndrome (Multiple sites)	0.002	0.998	0.000
M05.29 Rheumatoid vasculitis (Site unspecified)	0.002	0.998	0.000
M05.28 Rheumatoid vasculitis (Other)	0.002	0.998	0.000
M05.27 Rheumatoid vasculitis (Ankle and foot)	0.002	0.998	0.000
M05.26 Rheumatoid vasculitis (Lower leg)	0.002	0.998	0.000
M05.25 Rheumatoid vasculitis (Pelvic region and thigh)	0.002	0.998	0.000
M05.24 Rheumatoid vasculitis (Hand)	0.002	0.998	0.000
M05.23 Rheumatoid vasculitis (Forearm)	0.002	0.998	0.000
M05.22 Rheumatoid vasculitis (Upper arm)	0.002	0.998	0.000
M05.21 Rheumatoid vasculitis (Shoulder region)	0.002	0.998	0.000
M05.20 Rheumatoid vasculitis (Multiple sites)	0.002	0.998	0.000
M05.39 Rheumatoid arthritis with involvement of other organs and systems (Site unspecified)	0.002	0.998	0.000
M05.38 Rheumatoid arthritis with involvement of other organs and systems (Other)	0.002	0.998	0.000
M05.37 Rheumatoid arthritis with involvement of other organs and systems (Ankle and foot)	0.002	0.998	0.000
M05.36 Rheumatoid arthritis with involvement of other organs and systems (Lower leg)	0.002	0.998	0.000
M05.35 Rheumatoid arthritis with involvement of other organs and systems (Pelvic region and thigh)	0.002	0.998	0.000
M05.34 Rheumatoid arthritis with involvement of other organs and systems (Hand)	0.002	0.998	0.000
M05.33 Rheumatoid arthritis with involvement of other organs and systems (Forearm)	0.002	0.998	0.000
M05.32 Rheumatoid arthritis with involvement of other organs and systems (Upper arm)	0.002	0.998	0.000
M05.31 Rheumatoid arthritis with involvement of other organs and systems (Shoulder region)	0.002	0.998	0.000
M05.30 Rheumatoid arthritis with involvement of other organs and systems (Multiple sites)	0.002	0.998	0.000
S42.31 Fracture of shaft of humerus (open)	0.000	0.998	0.002
T83.2 Mechanical complication of graft of urinary organ	0.002	0.998	0.000
M05.89 Other seropositive rheumatoid arthritis (Site unspecified)	0.002	0.998	0.000
M05.88 Other seropositive rheumatoid arthritis (Other)	0.002	0.998	0.000
M05.87 Other seropositive rheumatoid arthritis (Ankle and foot)	0.002	0.998	0.000
M05.86 Other seropositive rheumatoid arthritis (Lower leg)	0.002	0.998	0.000
M05.85 Other seropositive rheumatoid arthritis (Pelvic region and thigh)	0.002	0.998	0.000
M05.84 Other seropositive rheumatoid arthritis (Hand)	0.002	0.998	0.000
M05.83 Other seropositive rheumatoid arthritis (Forearm)	0.002	0.998	0.000
M05.82 Other seropositive rheumatoid arthritis (Upper arm)	0.002	0.998	0.000
M05.81 Other seropositive rheumatoid arthritis (Shoulder region)	0.002	0.998	0.000
T63 Toxic effect of contact with venomous animals	0.002	0.998	0.000
M05.80 Other seropositive rheumatoid arthritis (Multiple sites)	0.002	0.998	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.000	0.998	0.002
T56.8 Other metals	0.002	0.998	0.000
T58 Toxic effect of carbon monoxide	0.002	0.998	0.000
Z74.3 Need for continuous supervision	0.002	0.998	0.000
S42.41 Fracture of lower end of humerus (open)	0.000	0.998	0.002
H57.1 Ocular pain	0.000	0.998	0.002
O20.8 Other haemorrhage in early pregnancy	0.000	0.998	0.002
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history	0.000	0.998	0.002
Q44.6 Cystic disease of liver	0.000	0.998	0.002
T51.9 Alcohol, unspecified	0.002	0.998	0.000
D68.1 Hereditary factor XI deficiency	0.002	0.998	0.000
Q38.7 Pharyngeal pouch	0.000	0.998	0.002
T63.4 Venom of other arthropods	0.002	0.998	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
S99.9 Unspecified injury of ankle and foot	0.000	0.998	0.002
D68.6 Other Thrombophilia	0.002	0.998	0.000
N28.8 Other specified disorders of kidney and ureter	0.002	0.998	0.000
N28.1 Cyst of kidney, acquired	0.000	0.998	0.002
D68.0 Von Willebrand's disease	0.002	0.998	0.000
G83.9 Paralytic syndrome, unspecified	0.000	0.998	0.002
H11.2 Conjunctival scars	0.000	0.998	0.002
Z45.2 Adjustment and management of vascular access device	0.000	0.998	0.002
L05 Pilonidal cyst	0.000	0.998	0.002
T54 Toxic effect of corrosive substances	0.002	0.998	0.000
S42.70 Multiple fractures of clavicle, scapula and humerus (closed)	0.000	0.998	0.002
H11.1 Conjunctival degenerations and deposits	0.000	0.998	0.002
T65 Toxic effect of other and unspecified substances	0.002	0.998	0.000
T62 Toxic effect of other noxious substances eaten as food	0.002	0.998	0.000
T61 Toxic effect of noxious substances eaten as seafood	0.002	0.998	0.000
T60 Toxic effect of pesticides	0.002	0.998	0.000
T57 Toxic effect of other inorganic substances	0.002	0.998	0.000
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.002	0.998	0.000
T52 Toxic effect of organic solvents	0.002	0.998	0.000
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.002	0.998	0.000
T55 Toxic effect of soaps and detergents	0.002	0.998	0.000
Q21.1 Atrial septal defect	0.002	0.998	0.000
G83.5 Locked-in syndrome	0.000	0.998	0.002
G83.3 Monoplegia, unspecified	0.000	0.998	0.002
G83.0 Diplegia of upper limbs	0.000	0.998	0.002
S42.7 Multiple fractures of clavicle, scapula and humerus	0.000	0.998	0.002
O20 Haemorrhage in early pregnancy	0.000	0.998	0.002
S42 Fracture of shoulder and upper arm	0.000	0.998	0.002
S42.1 Fracture of scapula	0.000	0.998	0.002
Z35.1 Supervision of pregnancy with history of abortive outcome	0.000	0.998	0.002
S42.10 Fracture of scapula (closed)	0.000	0.998	0.002
L27.1 Localised skin eruption due to drugs and medicaments	0.002	0.998	0.000
T56.9 Metal, unspecified	0.001	0.998	0.000
T56.7 Beryllium and its compounds	0.001	0.998	0.000
T56.6 Tin and its compounds	0.001	0.998	0.000
T56.5 Zinc and its compounds	0.001	0.998	0.000
T56.4 Copper and its compounds	0.001	0.998	0.000
T56.3 Cadmium and its compounds	0.001	0.998	0.000
T56.2 Chromium and its compounds	0.001	0.998	0.000
T56.1 Mercury and its compounds	0.001	0.998	0.000
T56.0 Lead and its compounds	0.001	0.998	0.000
Z35.7 Supervision of high-risk pregnancy due to social problems	0.000	0.998	0.002
Z35.6 Supervision of very young primigravida	0.000	0.998	0.002
Z35.3 Supervision of pregnancy with history of insufficient antenatal care	0.000	0.998	0.002
Z74.0 Reduced mobility	0.002	0.998	0.000
O20-O29 Other maternal disorders predominantly related to pregnancy	0.000	0.998	0.002
M50.9 Cervical disk disorder, unspecified	0.000	0.998	0.002
K50.1 Crohn's disease of large intestine	0.000	0.998	0.002
T63.9 Toxic effect of contact with unspecified venomous animal	0.001	0.998	0.000
T63.8 Toxic effect of contact with other venomous animals	0.001	0.998	0.000
T63.6 Toxic effect of contact with other marine animals	0.001	0.998	0.000
T63.5 Toxic effect of contact with fish	0.001	0.998	0.000
T63.3 Venom of spider	0.001	0.998	0.000
T63.2 Venom of scorpion	0.001	0.998	0.000
T63.1 Venom of other reptiles	0.001	0.998	0.000
T63.0 Snake venom	0.001	0.998	0.000
Z35.5 Supervision of elderly primigravida	0.000	0.998	0.002
M50 Cervical disk disorders	0.000	0.998	0.002
T59 Toxic effect of other gases, fumes and vapours	0.002	0.998	0.000
M21.27 Flexion deformity (Ankle and foot)	0.002	0.998	0.000
G83.8 Other specified paralytic syndromes	0.000	0.998	0.001
Q21.0 Ventricular septal defect	0.002	0.998	0.000
T54.9 Corrosive substance, unspecified	0.001	0.998	0.000
M24.15 Other articular cartilage disorders (Pelvic region and thigh)	0.002	0.998	0.000
K82.0 Obstruction of gallbladder	0.002	0.998	0.000
M10.97 Gout, unspecified (Ankle and foot)	0.000	0.998	0.002
H11.9 Disorder of conjunctiva, unspecified	0.000	0.998	0.001
L29.0 Pruritus ani	0.000	0.998	0.002
T54.3 Corrosive alkalis and alklali-like substances	0.001	0.998	0.000
T54.2 Corrosive acids and acid-like substances	0.001	0.998	0.000
T54.1 Other corrosive organic compounds	0.001	0.998	0.000
T54.0 Phenol and phenol homologues	0.001	0.998	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.002	0.998	0.000
T52.9 Organic solvent, unspecified	0.001	0.998	0.000
T52.8 Other organic solvents	0.001	0.998	0.000
T52.4 Ketones	0.001	0.998	0.000
T52.3 Glycols	0.001	0.998	0.000
T52.2 Homologues of benzene	0.001	0.998	0.000
T52.1 Benzene	0.001	0.998	0.000
T52.0 Petroleum products	0.001	0.998	0.000
T53.9 Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified	0.001	0.998	0.000
T53.7 Other halogen derivatives of aromatic hydrocarbons	0.001	0.998	0.000
T53.6 Other halogen derivatives of aliphatic hydrocarbons	0.001	0.998	0.000
T53.5 Chlorofluorocarbons	0.001	0.998	0.000
T53.4 Dichloromethane	0.001	0.998	0.000
T53.3 Tetrachloroethylene	0.001	0.998	0.000
T53.2 Trichloroethylene	0.001	0.998	0.000
T53.1 Chloroform	0.001	0.998	0.000
T53.0 Carbon tetrachloride	0.001	0.998	0.000
T57.9 Inorganic substance, unspecified	0.001	0.998	0.000
T57.8 Other specified inorganic substances	0.001	0.998	0.000
T57.3 Hydrogen cyanide	0.001	0.998	0.000
T57.2 Manganese and its compounds	0.001	0.998	0.000
T57.1 Phosphorus and its compounds	0.001	0.998	0.000
T57.0 Arsenic and its compounds	0.001	0.998	0.000
T60.9 Pesticide, unspecified	0.001	0.998	0.000
T60.8 Other pesticides	0.001	0.998	0.000
T60.4 Rodenticides	0.001	0.998	0.000
T60.3 Herbicides and fungicides	0.001	0.998	0.000
T60.2 Other insecticides	0.001	0.998	0.000
T60.1 Halogenated insecticides	0.001	0.998	0.000
T60.0 Organophosphate and carbamate insecticides	0.001	0.998	0.000
T61.9 Toxic effect of unspecified seafood	0.001	0.998	0.000
T61.8 Toxic effect of other seafoods	0.001	0.998	0.000
T61.2 Other fish and shellfish poisoning	0.001	0.998	0.000
T61.1 Scombroid fish poisoning	0.001	0.998	0.000
T61.0 Ciguatera fish poisoning	0.001	0.998	0.000
T62.9 Noxious substance eaten as food, unspecified	0.001	0.998	0.000
T62.8 Other specified noxious substances eaten as food	0.001	0.998	0.000
T62.2 Other ingested (parts of) plant(s)	0.001	0.998	0.000
T62.1 Ingested berries	0.001	0.998	0.000
T62.0 Ingested mushrooms	0.001	0.998	0.000
T65.8 Toxic effect of other specified substances	0.001	0.998	0.000
T65.6 Paints and dyes, not elsewhere classified	0.001	0.998	0.000
T65.5 Nitroglycerin and other nitric acids and esters	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations